These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18511884)

  • 21. Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.
    Wang Y; Wei Y; Zhang H; Shi Y; Li Y; Li R
    Med Oncol; 2012 Jun; 29(2):1328-34. PubMed ID: 21308489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
    Ramos AM; Aller P
    Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An ROS generator, antimycin A, inhibits the growth of HeLa cells via apoptosis.
    Park WH; Han YW; Kim SH; Kim SZ
    J Cell Biochem; 2007 Sep; 102(1):98-109. PubMed ID: 17372917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.
    Park WH
    Oncol Rep; 2012 May; 27(5):1611-8. PubMed ID: 22293863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells.
    Woo SH; Park IC; Park MJ; Lee HC; Lee SJ; Chun YJ; Lee SH; Hong SI; Rhee CH
    Int J Oncol; 2002 Jul; 21(1):57-63. PubMed ID: 12063550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on propyl gallate-treated HeLa cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2009 Aug; 24(2):261-8. PubMed ID: 19578799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation of MG132-induced HeLa cell death by N-acetyl cysteine via reducing reactive oxygen species and preventing glutathione depletion.
    Han YH; Yang YM; Kim SZ; Park WH
    Anticancer Res; 2010 Jun; 30(6):2107-12. PubMed ID: 20651358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
    Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
    Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways.
    Ho SY; Wu WJ; Chiu HW; Chen YA; Ho YS; Guo HR; Wang YJ
    Chem Biol Interact; 2011 Sep; 193(2):162-71. PubMed ID: 21741957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosis.
    Morales AA; Gutman D; Cejas PJ; Lee KP; Boise LH
    J Biol Chem; 2009 May; 284(19):12886-95. PubMed ID: 19279006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
    Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells.
    Golemovic M; Quintás-Cardama A; Manshouri T; Orsolic N; Duzkale H; Johansen M; Freireich EJ; Kantarjian H; Zingaro RA; Verstovsek S
    Invest New Drugs; 2010 Aug; 28(4):402-12. PubMed ID: 19468689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomib.
    Huang M; Thomas D; Li MX; Feng W; Chan SM; Majeti R; Mitchell BS
    Leukemia; 2013 Oct; 27(10):1970-80. PubMed ID: 23877794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism.
    Bowling BD; Doudican N; Manga P; Orlow SJ
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):37-43. PubMed ID: 18297286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular targets of arsenic trioxide in malignant cells.
    Miller WH
    Oncologist; 2002; 7 Suppl 1():14-9. PubMed ID: 11961205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.
    Liu Q; Hilsenbeck S; Gazitt Y
    Blood; 2003 May; 101(10):4078-87. PubMed ID: 12531793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.